ミシガン州における前立腺がんの臨床試験
ミシガン州内の拠点で、前立腺がんに関する56件の研究が参加者を募集しています。
ミシガン州内の都市
- Ann Arbor27件の研究
- Detroit22件の研究
- Grand Rapids19件の研究
- Lansing10件の研究
- Farmington Hills8件の研究
- Clinton Township8件の研究
- Canton8件の研究
- Flint7件の研究
- Waterford7件の研究
- Warren7件の研究
- Livonia7件の研究
- Dearborn6件の研究
- Saginaw5件の研究
- Troy5件の研究
- Jackson4件の研究
- Kalamazoo3件の研究
- Wyoming3件の研究
公式研究テキスト（英語）
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea
- 他8件
被験者募集中第3相
18歳以上 · 男性 · 2026/10/02更新 · NCT06931340Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Bronson Battle Creek, Battle Creek
- Henry Ford Cancer Institute-Downriver, Brownstown
- 他17件
被験者募集中第3相
18歳以上 · 男性 · 2026/10/02更新 · NCT07200830A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MyMichigan Medical Center Gratiot, Alma
- MyMichigan Medical Center Alpena, Alpena
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- 他68件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea
- 他3件
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
- Trinity Health Medical Center - Brighton, Brighton
- 他32件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382Precision-Based Genomics in Prostate Cancer
- University of Michigan, Ann Arbor
被験者募集中観察研究
18歳〜120歳 · 男性 · 2026/09/28更新 · NCT04706663Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Research Site, Ann Arbor
- Research Site, Detroit
被験者募集中第1/2相
18歳〜130歳 · 男性 · 2026/09/25更新 · NCT07181161Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- South Texas Accelerated Research Therapeutics, LLC (START), Grand Rapids
被験者募集中第1/2相
18歳以上 · 男性 · 2026/09/25更新 · NCT06800313A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Henry Ford Hospital ( Site 0015), Detroit
- Cancer and Hematology Centers of Western Michigan ( Site 0005), Grand Rapids
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06136650A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
- Start Midwest, Grand Rapids
被験者募集中第1相
18歳以上 · 男性 · 2026/09/25更新 · NCT07746713This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Michigan Institute of Urology, PC, Troy
被験者募集中第3相
18歳以上 · 男性 · 2026/09/24更新 · NCT07028853A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- START Midwest, Grand Rapids
被験者募集中第1相
18歳以上 · 男性 · 2026/09/24更新 · NCT07719361A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Barbara Ann Karmanos Cancer Institute, Detroit
- BAMF Health Inc., Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07114601A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Barbara Ann Karmanos Cancer Institute, Lansing
被験者募集中第3相
18歳以上 · 男性 · 2026/09/22更新 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Karmanos Cancer Institute, Detroit
被験者募集中第3相
18歳〜100歳 · 男性 · 2026/09/22更新 · NCT06855277Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])
- BAMF Health, Grand Rapids
被験者募集中第2/3相
18歳以上 · 男性 · 2026/09/21更新 · NCT07831824Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
被験者募集中第2相
18歳以上 · 男性 · 2026/09/17更新 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- University of Michigan ( Site 0005), Ann Arbor
- Henry Ford Hospital ( Site 0035), Detroit
- Cancer and Hematology Centers of Western Michigan ( Site 0015), Grand Rapids
被験者募集中第3相
18歳以上 · 男性 · 2026/09/17更新 · NCT06925737First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- GSK Investigational Site, Grand Rapids
被験者募集中第1/2相
18歳以上 · 男性 · 2026/09/16更新 · NCT07332455A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- BAMF Health, Grand Rapids
被験者募集中第1相
18歳以上 · 男性 · 2026/09/15更新 · NCT07581184Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Wayne State University, Detroit
被験者募集中
18歳以上 · 男性 · 2026/09/14更新 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- BAMF Health, Grand Rapids
- Corewell Health, Grand Rapids
被験者募集中第3相
18歳以上 · 男性 · 2026/09/11更新 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Trinity Health Medical Center - Brighton, Brighton
- 他21件
被験者募集中第3相
18歳以上 · 男性 · 2026/09/10更新 · NCT05946213A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
- Research Site, Grand Rapids
被験者募集中第1/2相
18歳以上 · 男性 · 2026/09/02更新 · NCT07192614Prostate Active Surveillance Study
- University of Michigan, Ann Arbor
被験者募集中観察研究
21歳以上 · 男性 · 2026/09/02更新 · NCT00756665The Vanguard Study: Testing a New Way to Screen for Cancer
- Henry Ford Cancer Institute-Downriver, Brownstown
- Henry Ford Health Center - Brownstown, Brownstown
- Henry Ford Health Center - Chesterfield, Chesterfield
- 他13件
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898COMPASS Study for Metastatic Castration-resistant Prostate Cancer
- Rogel Cancer Center, Ann Arbor
被験者募集中観察研究
18歳以上 · 男性 · 2026/08/27更新 · NCT07050433AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Grand Rapids
被験者募集中第3相
18歳以上 · 男性 · 2026/08/26更新 · NCT07611110Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Henry Ford, Novi
被験者募集中第2相
18歳以上 · 男性 · 2026/08/24更新 · NCT07745361A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Karmanos Cancer Institute, Detroit
被験者募集中第1/2相
18歳以上 · 男性 · 2026/08/20更新 · NCT06785636EDRN Prostate MRI Biomarker Study
- University of Michigan, Ann Arbor
被験者募集中観察研究
18歳以上 · 男性 · 2026/08/17更新 · NCT03784924Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
- University of Michigan Health, Ann Arbor
被験者募集中第2相
18歳以上 · 男性 · 2026/08/14更新 · NCT04812366SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy
- University of Michigan Comprehensive Cancer Center, Ann Arbor
被験者募集中観察研究
18歳以上 · 男性 · 2026/07/27更新 · NCT07096999Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Veteran's Administration Medical Center - Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- McLaren Cancer Institute-Bay City, Bay City
- 他19件
被験者募集中第3相
18歳以上 · 男性 · 2026/07/14更新 · NCT06592924Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- Karmanos, Detroit
被験者募集中第1相
18歳以上 · 男性 · 2026/07/09更新 · NCT05413421Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
- Karmanos Cancer Institute, Detroit
被験者募集中
20歳〜79歳 · 全性別 · 2026/06/23更新 · NCT07436078Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- McLaren Proton Therapy Center, Flint
被験者募集中
18歳以上 · 男性 · 2026/06/17更新 · NCT00969111Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- VA Ann Arbor Healthcare System, Ann Arbor
被験者募集中第2相
18歳以上 · 男性 · 2026/06/15更新 · NCT05422911Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
- University of Michigan Rogel Cancer Center, Ann Arbor
被験者募集中観察研究
35歳〜70歳 · 男性 · 2026/06/12更新 · NCT07645391ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。